🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/1991 | 19,24 | 19,42 | 19,16 | 19,16 | -0,82% | 1,34% | 3.600.509 |
| 29/05/1991 | 19,40 | 19,48 | 19,28 | 19,32 | -0,41% | 1,02% | 2.715.787 |
| 28/05/1991 | 19,24 | 19,40 | 19,12 | 19,40 | +0,93% | 1,45% | 3.133.939 |
| 24/05/1991 | 19,22 | 19,32 | 19,08 | 19,22 | -0,21% | 1,24% | 2.451.691 |
| 23/05/1991 | 19,30 | 19,44 | 19,12 | 19,26 | -0,41% | 1,65% | 3.510.590 |
| 22/05/1991 | 19,44 | 19,44 | 19,20 | 19,34 | -0,21% | 1,23% | 2.529.662 |
| 21/05/1991 | 19,06 | 19,54 | 19,02 | 19,38 | +1,88% | 2,71% | 5.076.931 |
| 20/05/1991 | 18,96 | 19,28 | 18,92 | 19,02 | +0,53% | 1,89% | 4.375.819 |
| 17/05/1991 | 18,69 | 19,04 | 18,53 | 18,92 | +0,53% | 2,77% | 8.190.120 |
| 16/05/1991 | 18,67 | 18,83 | 18,59 | 18,83 | +1,39% | 1,28% | 4.477.685 |
| 15/05/1991 | 18,61 | 18,69 | 18,37 | 18,57 | -0,43% | 1,71% | 5.044.234 |
| 14/05/1991 | 18,73 | 18,77 | 18,47 | 18,65 | -1,05% | 1,59% | 3.404.323 |
| 13/05/1991 | 18,87 | 18,87 | 18,75 | 18,85 | +0,11% | 0,63% | 3.494.870 |
| 10/05/1991 | 18,98 | 19,10 | 18,79 | 18,83 | -0,42% | 1,68% | 5.427.173 |
| 09/05/1991 | 18,65 | 18,91 | 18,65 | 18,91 | +1,60% | 1,39% | 4.894.579 |
| 08/05/1991 | 18,69 | 18,77 | 18,59 | 18,61 | -0,43% | 0,96% | 4.098.518 |
| 07/05/1991 | 18,51 | 18,89 | 18,51 | 18,69 | +0,97% | 2,04% | 6.111.936 |
| 06/05/1991 | 18,25 | 18,57 | 18,19 | 18,51 | +0,87% | 2,07% | 3.843.226 |
| 03/05/1991 | 17,91 | 18,37 | 17,89 | 18,35 | +2,21% | 2,66% | 3.581.016 |
| 02/05/1991 | 17,81 | 17,97 | 17,81 | 17,95 | +1,23% | 0,89% | 5.007.763 |
| 01/05/1991 | 17,22 | 17,73 | 17,16 | 17,73 | +3,48% | 3,35% | 4.927.277 |
| 30/04/1991 | 17,26 | 17,33 | 17,10 | 17,14 | +0,00% | 1,38% | 4.869.427 |
| 29/04/1991 | 17,37 | 17,57 | 17,08 | 17,14 | -1,15% | 2,86% | 4.421.722 |
| 26/04/1991 | 17,29 | 17,47 | 17,24 | 17,33 | -0,57% | 1,38% | 2.932.723 |
| 25/04/1991 | 17,33 | 17,51 | 17,22 | 17,43 | +0,34% | 1,72% | 3.857.688 |
| 24/04/1991 | 17,49 | 17,53 | 17,26 | 17,37 | -0,57% | 1,59% | 4.134.989 |
| 23/04/1991 | 17,53 | 17,55 | 17,33 | 17,47 | +0,00% | 1,25% | 3.088.666 |
| 22/04/1991 | 17,57 | 17,63 | 17,41 | 17,47 | -1,01% | 1,24% | 4.356.326 |
| 19/04/1991 | 17,85 | 17,97 | 17,65 | 17,65 | -2,31% | 1,78% | 6.975.907 |
| 18/04/1991 | 18,13 | 18,19 | 17,99 | 18,07 | -0,98% | 1,10% | 2.794.387 |